Overview
Sutterella wadsworthensis is a Gram-negative, bile-resistant, microaerophilic bacterium that resides primarily in the human gastrointestinal tract. It belongs to the family Sutterellaceae within the phylum Proteobacteria. This organism is notable for its gradient distribution along the intestinal tract, with highest concentrations found in the duodenum and decreasing abundance toward the colon. Research suggests that Sutterella species may constitute up to 19% of total duodenal microbiota in some individuals, making it a potentially significant member of the small intestinal microbial community.
Classification
S. wadsworthensis is classified within the class Betaproteobacteria, order Burkholderiales, and family Sutterellaceae. The genus Sutterella currently includes three recognized species: S. wadsworthensis, S. parvirubra, and S. stercoricanis. The organism was originally isolated from infections of the gastrointestinal tract and named after the Wadsworth Anaerobe Laboratory. It is an obligately anaerobic to microaerophilic bacterium that can tolerate bile salts, which may contribute to its ability to colonize the upper gastrointestinal tract where bile concentrations are higher.
Key Characteristics
One of the most notable features of S. wadsworthensis is its production of an IgA-specific serine endopeptidase, an enzyme that cleaves immunoglobulin A (IgA) antibodies. This activity may reduce mucosal immune defense in the gut, potentially allowing other microorganisms to interact more readily with the intestinal epithelium. The organism also appears to bind mucus and extracellular matrix proteins, suggesting an intimate association with the intestinal mucosa. Studies have found that IgA protease-positive individuals tend to have altered gut microbiome profiles, including lower microbial diversity.
Health Significance
The health implications of S. wadsworthensis appear to be context-dependent. Research has associated elevated Sutterella levels with several conditions, including ulcerative colitis, autism spectrum disorder, and pediatric obesity. In some pediatric studies, S. wadsworthensis abundance has been directly correlated with obesity in adolescent girls, potentially through IgA endopeptidase disruption of intestinal antibacterial defense. Conversely, reduced Sutterella levels have been observed in patients with Crohn's disease, suggesting a possible protective role in certain inflammatory contexts. This dual nature makes S. wadsworthensis an organism of considerable interest in microbiome research, though its precise role in health and disease remains an area of active investigation. It may appear on comprehensive gut microbiome testing panels as part of broader community profiling.